Ana R Sousa Selected Research

Ana R Sousa Research Topics

Disease

30	Asthma (Bronchial Asthma) 09/2023 - 03/2002
11	Nasal Polyps (Nasal Polyp) 11/2023 - 11/2002
10	Rhinosinusitis 11/2023 - 11/2002
8	Inflammation (Inflammations) 01/2023 - 11/2016
5	Chronic Obstructive Pulmonary Disease (COPD) 12/2018 - 09/2015
3	Nasal Obstruction 11/2023 - 10/2021
3	Eosinophilia 11/2022 - 09/2013
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021 - 06/2017
1	Long Term Adverse Effects 11/2023
1	Respiratory Sounds (Crackle) 01/2023
1	Atopic Dermatitis (Atopic Eczema) 01/2023
1	Virus Diseases (Viral Diseases) 01/2022
1	Polyps 01/2022
1	Sinusitis 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Eczema 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2019
1	Airway Remodeling 01/2017
1	Dyspnea (Shortness of Breath) 01/2017
1	Overweight 09/2013
1	Weight Loss (Weight Reduction) 09/2013
1	Respiratory Hypersensitivity 11/2002
1	Bronchial Hyperreactivity 03/2002
1	Glucocorticoid Receptor Deficiency 03/2002
1	Airway Obstruction (Choking) 03/2002

Drug/Important Bio-Agent (IBA)

16	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023 - 11/2015
11	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
7	mepolizumabIBA 11/2023 - 10/2017
4	Interleukin-5 (Interleukin 5)IBA 01/2023 - 09/2013
4	SteroidsIBA 01/2022 - 11/2016
4	GSK573719IBA 12/2018 - 09/2015
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 06/2017
3	Interleukin-13IBA 11/2019 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2002
3	vilanterolIBA 12/2018 - 09/2015
3	Bronchodilator Agents (Bronchodilators)IBA 12/2018 - 12/2016
2	Prednisolone (Predate)FDA LinkGeneric 11/2023 - 01/2021
2	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2022 - 12/2016
2	InterleukinsIBA 11/2022 - 01/2019
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 11/2002
2	LeukotrienesIBA 01/2021 - 11/2002
2	Interleukin-6 (Interleukin 6)IBA 11/2019 - 01/2019
2	Immunoglobulin E (IgE)IBA 01/2019 - 06/2017
2	ProteomeIBA 01/2019 - 01/2018
2	tiotropium-olodaterolIBA 12/2018 - 11/2017
2	Fluticasone (Cutivate)FDA LinkGeneric 01/2017 - 12/2016
2	Salmeterol Xinafoate (Serevent)FDA Link 01/2017 - 12/2016
2	Capsules (Microcapsules)IBA 01/2017 - 12/2016
2	PowdersIBA 01/2017 - 12/2016
1	Anabolic Androgenic SteroidsIBA 09/2023
1	AndrogensIBA 09/2023
1	16S Ribosomal RNAIBA 01/2023
1	LipidsIBA 01/2023
1	Albuterol (Salbutamol)FDA LinkGeneric 01/2023
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	P-2 (P 2)IBA 01/2022
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2022
1	Prostaglandin D2IBA 01/2021
1	ProstaglandinsIBA 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2021
1	Omalizumab (Xolair)FDA Link 01/2021
1	EicosanoidsIBA 01/2021
1	Leukotriene E4IBA 01/2021
1	IsoprostanesIBA 01/2021
1	ElastinIBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 11/2019
1	DefensinsIBA 11/2019
1	Thromboxane B2IBA 11/2019
1	Interleukin-17 (Interleukin 17)IBA 11/2019
1	PeriostinIBA 01/2019
1	Interleukin-4 (Interleukin 4)IBA 01/2019
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	EnzymesIBA 01/2018
1	AntioxidantsIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Muscarinic AntagonistsIBA 11/2017
1	ChemokinesIBA 10/2017
1	InterferonsIBA 01/2017
1	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 01/2017
1	hydroxyethyl methacrylate (HEMA)IBA 11/2016
1	fluticasone furoate FDA Link 09/2015
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 11/2002
1	cysteinyl-leukotrieneIBA 11/2002
1	Leukotriene Receptors (Leukotriene Receptor)IBA 11/2002
1	Protein Isoforms (Isoforms)IBA 03/2002
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 03/2002
1	GlucocorticoidsIBA 03/2002

Therapy/Procedure

11	Therapeutics 01/2022 - 03/2002
2	Nebulizers and Vaporizers (Inhaler) 01/2017 - 12/2016
1	Nasal Surgical Procedures 10/2021
1	Electronic Nose 01/2019